Letter: The ethics of using inferior regimens in H. pylori randomised trials - Invited comment

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 7, 2012, Pages 856-857

  Gisbert, J P ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLINICAL RESEARCH; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; INFECTION CONTROL; LETTER; MEDICAL ETHICS; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; FEMALE; HELICOBACTER INFECTIONS; HUMANS; MALE; PROTON PUMP INHIBITORS;

EID: 84858247331     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04985.x     Document Type: Letter

References (10)

1. Malfertheiner P, Megraud F, O'Morain C, et al,. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-81. (Pubitemid 46854190)
2. Gisbert JP, Calvet X,. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Aliment Pharmacol Ther 2011; 34: 1255-68.
3. Gisbert JP, Calvet X, O'Connor A, Megraud F, O'Morain CA,. Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol 2010; 44: 313-25.
4. Gisbert JP, Calvet X,. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Aliment Pharmacol Ther 2011; 34: 604-17.
5. Gisbert JP,. Is culture necessary before first-line treatment for Helicobacter pylori infection? Intern Med 2011; 50: 2717.
6. Graham DY,. Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol 2009; 7: 145-8.
7. Graham DY,. Helicobacter pylori eradication therapy research: ethical issues and description of results. Clin Gastroenterol Hepatol 2010; 8: 1032-6.
8. Graham DY, Fischbach LA,. Letter: the ethics of using inferior regimens in H. pylori randomised trials. Aliment Pharmacol Ther 2012; 35: 852-4.
9. Wu DC, Hsu PI, Wu JY, et al,. Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection. Clin Gastroenterol Hepatol 2010; 8: 36-41, e1.
10. Study comparing sequential and concomitant therapy for Helicobacter pylori eradication in routine clinical practice. ClinicalTrials.gov Identifier: NCT01273441.